Creative Medical Technology Holdings Inc CELZ
Dividend Summary
There have not been any declared dividends recently.
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | – | – |
| Type | – | – |
| Per share | – | – |
| Declaration date | – | – |
| Ex-div date | – | – |
| Pay date | – | – |
Enter the number of Creative Medical Technology Holdings Inc shares you hold and we'll calculate your dividend payments:
Sign up for Creative Medical Technology Holdings Inc and we'll email you the dividend information when they declare.
Add Creative Medical Technology Holdings Inc to receive free notifications when they declare their dividends.
Your account is set up to receive Creative Medical Technology Holdings Inc notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| There are no Creative Medical Technology Holdings Inc dividends. | ||||||||
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0c | — |
| 2007 | 0.0c | 0% |
| 2008 | 0.0c | 0% |
| 2009 | 0.0c | 0% |
| 2010 | 0.0c | 0% |
| 2011 | 0.0c | 0% |
| 2012 | 0.0c | 0% |
| 2013 | 0.0c | 0% |
| 2014 | 0.0c | 0% |
| 2015 | 0.0c | 0% |
| 2016 | 0.0c | 0% |
| 2017 | 0.0c | 0% |
| 2018 | 0.0c | 0% |
| 2019 | 0.0c | 0% |
| 2020 | 0.0c | 0% |
| 2021 | 0.0c | 0% |
| 2022 | 0.0c | 0% |
| 2023 | 0.0c | 0% |
| 2024 | 0.0c | 0% |
| 2025 | Sign Up Required | |
Creative Medical Technology Holdings Inc Optimized Dividend Chart
- Dividend Yield Today
- 0.0%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 0.0% on 18 July 2024
- 52 Week Low
- 0.0% on 18 July 2024
- Next Ex-Div-Date Countdown
- Sign Up Required
About Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company. The Company is focused on immunology, urology, neurology, and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The Company conducts its commercial operations through its subsidiary, Creative Medical Technologies, Inc. (CMT). CMT markets and sells its CaverStem and FemCelz disposable kits utilized by physicians to perform autologous procedures that treat erectile dysfunction (ED) and female sexual dysfunction, respectively. Its products include CaverStem, FemCelz, StemSpine, ImmCelz and OvaStem. StemSpine is a regenerative stem cell procedure for the treatment of degenerative disc disease. ImmCelz is a universal donor stem cell therapy for stroke treatment. OvaStem is a stem cell therapy for premature ovarian failure. It is also focused on the use of its technologies covering treatments for various diseases.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- United States
- Share Price
- $2.62 (yesterday's closing price)
- Shares in Issue
- 3 million
- Market Cap
- $7mn
- 0
- Market Indices
- none
